Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

Norris, RE; Fox, E; Reid, JM; Ralya, A; Liu, XWW; Minard, C; Weigel, BJ

Norris, RE (reprint author), Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Oncol, 3333 Burnet Ave,MLC 7018, Cincinnati, OH 45229 USA.

PEDIATRIC BLOOD & CANCER, 2018; 65 (5):

Abstract

BackgroundOntuxizumab is a humanized IgG monoclonal antibody that targets the cell-surface glycoprotein endosialin (tumor endothelial marker-1[TEM-1]/......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索